ID   A0A285MTC4_9FLAO        Unreviewed;      1055 AA.
AC   A0A285MTC4;
DT   22-NOV-2017, integrated into UniProtKB/TrEMBL.
DT   22-NOV-2017, sequence version 1.
DT   27-MAR-2024, entry version 17.
DE   SubName: Full=Uncharacterized protein {ECO:0000313|EMBL:SNZ00432.1};
GN   ORFNames=SAMN06265377_2256 {ECO:0000313|EMBL:SNZ00432.1};
OS   Allomuricauda parva.
OC   Bacteria; Bacteroidota; Flavobacteriia; Flavobacteriales;
OC   Flavobacteriaceae; Allomuricauda.
OX   NCBI_TaxID=1247520 {ECO:0000313|EMBL:SNZ00432.1, ECO:0000313|Proteomes:UP000219048};
RN   [1] {ECO:0000313|Proteomes:UP000219048}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=DSM 25885 {ECO:0000313|Proteomes:UP000219048};
RA   Varghese N., Submissions S.;
RL   Submitted (SEP-2017) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; OBEH01000003; SNZ00432.1; -; Genomic_DNA.
DR   AlphaFoldDB; A0A285MTC4; -.
DR   OrthoDB; 9757809at2; -.
DR   Proteomes; UP000219048; Unassembled WGS sequence.
DR   CDD; cd15482; Sialidase_non-viral; 3.
DR   Gene3D; 2.130.10.10; YVTN repeat-like/Quinoprotein amine dehydrogenase; 3.
DR   InterPro; IPR036278; Sialidase_sf.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   PANTHER; PTHR12106; SORTILIN RELATED; 1.
DR   PANTHER; PTHR12106:SF27; VPS10 HOMOLOG 1-RELATED; 1.
DR   SUPFAM; SSF110296; Oligoxyloglucan reducing end-specific cellobiohydrolase; 1.
DR   SUPFAM; SSF50939; Sialidases; 1.
PE   4: Predicted;
SQ   SEQUENCE   1055 AA;  118259 MW;  A013275BBFBDDCE4 CRC64;
     MIQRFLIQCF VLSMALIQSG HAQIDNELFK HLDFRFIGPE GNRAIAIAGV PGDPMISYIG
     AASGGLWKTT DGGINWLPIF DDQDVSSIGS IAIAPSDPNI LWVGTGETFI IRPAHAMGDG
     IYKSEDAGKT WKHMGLEKTG RIGRVIVHPT DPNIVYVAAL GHTFGPQDER GVFKTTDGGK
     TWSKILFVDE STGAADIEID PKNPDNILVG MWSIKINTWG LNSGGAGGGV YRSKDGGKTW
     QAMKDYGLPG GKDHPVGKTG VAISPSNPSV AYALFEIDSP ALYRTDDFGE TWTLMTRNHD
     INERAPYYTR MRVSTDDPNE IYFANVKFIV SKDGGKTLEG GYTAGGDNHD IWIDPTNANR
     IMVAHDGCAS ISLNRGKTYQ RIVLPIAQMY HVATDNQIPY NVYGNRQDGY SYKGPSNSLQ
     GYIPLGLWKG VGGCESGFAQ PDPFDNNIVW SGCYDGGLER YNAKTGHAQD VRVWPEAGYG
     WAPKDMKYRW YWNFPLEFSN YVKHRVYVGS QFVHKSDDNG NSWQLISPDL TLNDKSHQQS
     SGGIAIDNLM TWDGAVLISI EESKLEEGVI WTGSNDGQVH LTKNFGKDWI NVSKNIPDLP
     EWGTISSIET SRYTKGTVYI TVDLHHMGNF DPFVYKTSDY GKSWKLVSST VPKSIHSFAH
     VIKEDPKKEG MLYLGVDNGL YISYDDGDNW MRFKNNLPPA PVYWLEIQEQ FDDLVVCTYG
     RGYYILDNIA PLREFATDVL DNEVHLFSIR QAYRFHDKQS IKTDGPSLNS GKNPAYGADI
     NYYLKENTKE KIEVQVLSQN NEVIRTLKGS NEVGVNRVMW DLRYEPTYKP YLRSTPPGRP
     WVQLNGEGWR PLVTWDLDLW RGQFGPKVVP GNYRVKLIVG EQEFVRDLTI LKDPKSEGSV
     EDIKEQVALS LELRDAMNIA VNMINTVEMI RSELNILIPK LTNDKDVEDA RRLQQKAESV
     AGLLYDIHLT GAREDAFRSP MKLYGRLSAL ASDLGGHGID FKPTKQQKEV AQIFNGRLKK
     ITDKFDNLVN LEIDKLNKQL EKSKLKVELK KKIKD
//